Viraferonpeg and hepatitis c Patient Reports February 11, 2012
Viraferonpeg Side Effects Report #4896326-8
Viraferonpeg side effect was reported by a Physician from FRANCE on Jan 16, 2006. Male patient, 67 years of age, weighting 123.5 lb, was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: atrioventricular block, disease recurrence, epilepsy
, hepatitis c
, loss of consciousness, syncope. Viraferonpeg dosage: unknown. Patient recovered.Viraferonpeg Side Effects Report #4761244-2
Viraferonpeg side effect was reported by a Physician from FRANCE on Aug 23, 2005. Female patient, 55 years of age, weighting 97.00 lb, was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: acute vestibular syndrome, balance disorder, cerebellar syndrome, condition aggravated, encephalopathy, hepatitis c
, immune reconstitution syndrome, non-hodgkin's lymphoma recurrent, nuclear magnetic resonance imaging abnormal. Viraferonpeg dosage: unknown. During the same period patient was treated with RIBAVIRIN, CORTANCYL, CORTICOSTEROID NOS, CORTICOSTEROID NOS, RECORMON. Patient was hospitalized and became disabled. Patient recovered.Viraferonpeg Side Effects Report #5800887-1
Viraferonpeg side effect was reported by a Physician from FRANCE on June 25, 2008. Male patient, 52 years of age, weighting 159.2 lb, was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: condition aggravated, cytolytic hepatitis, hepatitis c
. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, ACETAMINOPHEN. Patient recovered.Viraferonpeg Side Effects Report #5924026-1
Viraferonpeg side effect was reported by a Physician from FRANCE on Oct 08, 2008. Male patient, 52 years of age, weighting 159.2 lb, was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: condition aggravated, hepatitis c
. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, ACETAMINOPHEN. Patient recovered.Viraferonpeg Side Effects Report #5009199-X
Viraferonpeg side effect was reported by a Physician from FRANCE on May 10, 2006. Male patient, 32 years of age, weighting 163.1 lb, was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: accidental overdose, condition aggravated, disease recurrence, epistaxis, hepatitis c
, migraine without aura, vertigo, visual field defect. Viraferonpeg dosage: unknown. During the same period patient was treated with REBETOL, SUBUTEX, TERCIAN, VALIUM, STILNOX, DEROXAT. Patient recovered.Viraferonpeg Side Effects Report #4556524-X
Viraferonpeg side effect was reported by a Physician from on Jan 05, 2005. Male patient was diagnosed with hepatitis c
and was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: chest pain
, condition aggravated, erythema, hepatitis c
, loss of consciousness, malaise, palpitations, syncope, transaminases increased. Viraferonpeg dosage: unknown. Patient recovered.Viraferonpeg Side Effects Report #5531433-8
Viraferonpeg side effect was reported by a Physician from FRANCE on Nov 16, 2007. Female patient, 68 years of age, weighting 114.6 lb, was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: hepatitis c
. Viraferonpeg dosage: unknown. Patient was hospitalized. Patient recovered.Viraferonpeg Side Effects Report #5619274-4
Viraferonpeg side effect was reported by a Physician from FRANCE on Feb 01, 2008. Female patient, 68 years of age, weighting 114.6 lb, was treated with Viraferonpeg. After drug was administered, patient experienced the following side effects: hepatitis c
. Viraferonpeg dosage: unknown. Patient was hospitalized. Patient recovered.
Viraferonpeg and hepatitis c 